Cannon Financial Strategists, Inc. Merck & Co., Inc. Transaction History

Cannon Financial Strategists, Inc.

$572 Billion
Q3 2024

A detailed history of Cannon Financial Strategists, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cannon Financial Strategists, Inc. holds 3,916 shares of MRK stock, worth $396,181. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,916

Previous 3,705 5.7%

Holding current value

$396,181

Previous $404 Million 10.1%

% of portfolio

0.08%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$111.15 - $128.97 $23,452 - $27,212	211 Added 5.7%	3,916 $445 Million
Q2 2024 Sep 10, 2024	BUY	$123.8 - $132.96 $505,723 - $543,141	4,085 New	4,085 $506 Million
Q4 2023 Oct 18, 2024	SELL	$100.18 - $109.02 $38,068 - $41,427	-380 Reduced 9.3%	3,705 $404 Million
Q3 2023 Oct 18, 2024	SELL	$102.95 - $114.33 $4,220 - $4,687	-41 Reduced 1.1%	3,692 $380 Million
Q3 2023 Oct 02, 2024	SELL	$102.95 - $114.33 $364,031 - $404,270	-3,536 Closed	0 $0
Q1 2023 Oct 02, 2024	BUY	$102.94 - $114.86 $363,995 - $406,144	3,536 New	3,536 $376 Million
Q4 2022 Oct 18, 2024	BUY	$87.44 - $112.11 $2,448 - $3,139	28 Added 0.76%	3,733 $414 Million
Q4 2022 Oct 02, 2024	SELL	$87.44 - $112.11 $786,085 - $1.01 Million	-8,990 Closed	0 $0
Q3 2022 Oct 02, 2024	BUY	$84.53 - $94.96 $759,924 - $853,690	8,990 New	8,990 $689 Million
Q2 2022 Oct 18, 2024	BUY	$83.49 - $94.64 $7,931 - $8,990	95 Added 2.64%	3,691 $337 Million
Q1 2022 Oct 18, 2024	BUY	$73.51 - $82.4 $1,617 - $1,812	22 Added 0.62%	3,596 $295 Million
Q4 2021 Oct 18, 2024	SELL	$72.28 - $90.54 $9,468 - $11,860	-131 Reduced 3.54%	3,574 $274 Million
Q3 2021 Oct 02, 2024	SELL	$71.68 - $78.83 $17.1 Million - $18.8 Million	-238,883 Closed	0 $0
Q2 2021 Oct 02, 2024	BUY	$70.31 - $77.77 $16.5 Million - $18.3 Million	234,798 Added 5747.81%	238,883 $12.3 Billion
Q1 2021 Oct 02, 2024	BUY	$68.86 - $81.11 $1,583 - $1,865	23 Added 0.65%	3,574 $276 Million
Q4 2020 Oct 18, 2024	SELL	$71.77 - $79.65 $9,401 - $10,434	-131 Reduced 3.54%	3,574 $292 Million
Q4 2020 Oct 02, 2024	SELL	$71.77 - $79.65 $1,650 - $1,831	-23 Reduced 0.64%	3,551 $1.33 Billion
Q3 2020 Oct 02, 2024	SELL	$73.18 - $82.95 $37,394 - $42,387	-511 Reduced 12.51%	3,574 $296 Million
Q2 2020 Oct 18, 2024	SELL	$70.42 - $80.13 $6,056 - $6,891	-86 Reduced 2.32%	3,619 $280 Million
Q4 2019 Oct 02, 2024	BUY	$77.58 - $87.54 $4.75 Million - $5.36 Million	61,203 Added 1498.24%	65,288 $3.29 Billion

Others Institutions Holding MRK

# of Institutions

3,802

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $256B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannon Financial Strategists, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cannon Financial Strategists, Inc. with notifications on news.

Account

Cannon Financial Strategists, Inc. Merck & Co., Inc. Transaction History